The Food and Drug Administration yesterday provided an update on the HeartWare Ventricular Assist Device system. These updates include new recommendations for patients and providers; information related to FDA’s actions following a June 2022 recall related to battery electrical faults; details on recent recalls conducted by Medtronic including new ways to reduce damage to controller port pins; and information on the system’s pump weld defect.

Related News Articles

Headline
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…
Headline
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require…
Headline
All hospitals may request a backup controller with modified software for the Heartware Ventricular Assist Device System to use in certain circumstances if the…
Headline
The FBI today released recommendations to help protect medical devices from cyberattacks that can threaten health care operations, patient safety, and…
Headline
The AHA last week encouraged the Bureau of Land Management to work with the Health and Human Services Assistant Secretary for Preparedness and Response,…
Headline
The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding…